jueves, 29 de octubre de 2026
BuscarExplore
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
News articleYahoo Finance· February 23, 2026

Stock market today: Dow drops 800 points as S&P 500, Nasdaq slide on Trump tariff fears, AI 'scare trade'

View original at finance.yahoo.com
Stock market today: Dow drops 800 points as S&P 500, Nasdaq slide on Trump tariff fears, AI 'scare trade' US stocks retreated on Monday as investors grappled with the fallout from the Supreme Court's rebuff of President Trump's most sweeping tariffs, while AI disruption fears gripped markets once again…
Opening lines of the source · Yahoo Finance · short snapshot — read the full document at the original

Lo que extrajimos de esta fuente

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • All major regions were net sold, led by North America and Europe, with 58% single stocks and 42% macro products

    80% confidence
  • Rates two possible outcomes as close to a coin flip

    80% confidence
  • Brent rallied $11 YTD to $71 as Iran-related supply concerns drove positioning recovery while OECD inventories haven't built as expected

    80% confidence
  • A deal is a deal

    80% confidence
  • MORE strategy delivered higher sales and profits, with strong results flowing through to increased franchisee profits

    80% confidence
  • Current conditions remind them of similar sell-offs that led to 80%-190% total returns within 12 months

    80% confidence
  • Blue Owl's investment history is solid to strong across all strategies and credit quality remains above average

    80% confidence
  • Assuming underlying inflation continues to signal we are close to 2% goal, key to setting policy will be view of labor market

    80% confidence
  • There is significant misinformation weighing on Blue Owl and private credit industry, creating attractive buying opportunity

    80% confidence
  • Potential 1M barrel/day Iran supply disruption for 12 months would boost fair value of oil by $8

    80% confidence
  • Gatekeepers and majority of financial advisors are sticking to facts including +12% 3Y annualized returns

    80% confidence
  • WTI crude expected to fall to $56 in Q4, up from previous call of $48

    80% confidence
  • Brent crude expected to decline to $60/barrel in Q4, up from previous estimate of $54

    80% confidence
  • Hedge funds sold global stocks in week ended Feb. 19 at fastest pace since April 2025

    80% confidence
  • Private credit is attractive contributor to US retirees' portfolio given high returns, downside protection and monthly dividends

    80% confidence
  • If strong January jobs reading is revised lower, would reinforce January rate cut and signal need for another cut in March

    80% confidence
  • US will lift baseline tariff rate on imports to 15%, effective immediately

    80% confidence
  • If February labor data consistent with stronger job creation and low unemployment, may be appropriate to hold policy rate at current levels

    80% confidence

Citado en estos reportajes de Via News

Lo que sabemos · la inteligencia detrás de esta página
En vivo desde el sustrato
Lo que estamos viendo
ESMO 2026 Oncology Data Wave Builds Toward Ivonescimab PDUFA, While Micro-Cap Biotech Exits the Market
Late October 2026 is a dense catalyst window led by ESMO 2026. Daiichi Sankyo's DXd antibody-drug conjugate (ADC) programs (DESTINY-Lung04, DESTINY-Breast11, REJOICE-Ovarian01/02, TUXEDO-3), Guardant's 25 abstracts and the PACE-LUNG ctDNA trial all report there. These feed into the FDA's 14 November 2026 PDUFA date for ivonescimab. Large and mid-cap developers with late-stage data and commercial launches (ZEGFROVY, ANKTIVA, MIUDELLA, lorundrostat, duvakitug) are drawing capital and attention. Spago Nanomedical's board decision to seek a Nasdaq First North delisting (EGM 19 November, application 25 January 2027) shows the capital squeeze on early-stage, single-asset names (Tumorad is Phase I).
Nuestra lectura de los datos ›
Señales que seguimos
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patrones que observamos ›
Donde las fuentes discrepan
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
Señalamos los conflictos abiertamente ›
Verificado recientemente
✓ Verificado con la fuente original
4,994
hechos rastreados a su fuente — y señalamos los que no se sostienen.
101 entidades seguidas4,994 hechos verificados con la fuente5,503 documentos fuente archivados
Consulta estos datos → isubstrate.com